Presenting at the #ESC2023#ESCCongress about implementing of Integrated Care in #Afib patients! Let’s do more science for our patients! And still a lot more to come with #AFFIRMO project! @affirmo_eu @icsmaugeri @LaStatale
It is time to understand whether antiplatelet monotherapy paradigm needs to be changed!!! Congrats to @FeliceGragnano and colleagues for their achievement! @JACCJournals
📣 The @EASDacademy calls for new Committee Members! 👩🏻⚕️🧑🔬
Are you a member of @EASDnews, passionate about our mission?
Apply to join us!
🗓️ Deadline 16 April ‘23
➡️ Letter of motivation & CV
📧[email protected]
ℹ️ https://t.co/Yh1z2NmDFe
#diabetes#AcademicTwitter
Only few spots left!
@EASDacademy Journal Club: Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune #diabetes
🕔Today @ 5 pm CET
@EASDnews@DiabetologiaJnl
https://t.co/68RyTq6gek
📸🎓 C’è ancora tempo fino al #31gennaio per iscriversi a un master Sapienza!
Il termine per la presentazione della domanda di ammissione alla maggior parte dei master 2022-2023 è stato prorogato ➡️ https://t.co/2nFlbTTVcY
#IoScelgoSapienza#Arof_Sapienza#masterSapienza
Selezionati dal @Mur_gov_ 12 dipartimenti d'eccellenza della Sapienza, 4 in più rispetto al quinquennio 2018-2022
[leggi tutto su ➡️ https://t.co/7BSGi38Ko4]
📰 #Sapienzasuimedia#orgoglioSapienza https://t.co/y0D6Ijmnkc
New evidence about the relationship between functional impairment about pharmacological management of older patients enrolled in REPOSI Study #GIS#SIMI@MarioNegriIRCCS